Amsterdam Immunogenicity & Tolerance Seminar 2022

18/11/22

About the Amsterdam Immunogenicity & Tolerance Seminar:

Now in it’s 7^th year, the Amsterdam Immunogenicity & Tolerance Seminar has become a much anticipated forum for sharing research and ideas in the fields of immunogenicity and tolerance.  Academic and industry research has progressed significantly in the past several years, and many advances have been made in the areas of gene therapy, mRNA, CAR-T, and other novel platforms. In addition, traditional protein therapeutics research (still somewhat new as well), has expanded complexity to include Bispecific and Multispecifc antibodies, fusion proteins and peptide therapeutics. 2022 has also brought close attention to impurities including synthetic peptide impurities as well as Host Cell Proteins (HCP) where immunogenicity  both in the vaccine and biologics space is of concern. All of these exciting developments have generated many questions and added complexity for immunologists, drug developers and medical practitioners working to deliver safe and effective therapies.

Confirmed Speakers:

Annie De Groot, M.D., EpiVax

Brian Roberts, Ph.D., EpiVax

Kingston Mills, Ph.D., Trinity College, Dublin

Arjan Stoppelenburg, Ph.D., Utrecht University

Nicky Dunn, Ph.D., Karolinska Institutet

Additional speakers and a finalized agenda will be announced in the coming weeks.

You can find some additional information on this year’s seminar here: https://epivax.com/events/amsterdam-immunogenicity-tolerance-seminar-november-18-2022

Interested in attending this free event? Register here! https://bit.ly/EpiVaxAMS2022